Quality of Life after Breast Reduction Surgery

2011 ◽  
Vol 128 ◽  
pp. 105
Author(s):  
Marco A. Gonzalez ◽  
Jonathan Tan ◽  
Alexander B. Dagum ◽  
Mark Melendez ◽  
Arora Balavantry
2009 ◽  
Vol 34 (1) ◽  
pp. 59-64 ◽  
Author(s):  
Arnaldo A. Mello ◽  
Neide A. M. Domingos ◽  
M. Cristina Miyazaki

BMJ Open ◽  
2020 ◽  
Vol 10 (2) ◽  
pp. e031804
Author(s):  
Tamara Crittenden ◽  
David I Watson ◽  
Julie Ratcliffe ◽  
Philip A Griffin ◽  
Nicola R Dean

ObjectivesTo assess the health burden of breast hypertrophy and the comparative effectiveness of breast reduction surgery in improving health-related quality of life.DesignProspective cohort study.SettingA major public tertiary care hospital in Australia.ParticipantsWomen with symptomatic breast hypertrophy who underwent breast reduction surgery were followed for 12 months. A comparison control cohort comprised women with breast hypertrophy who did not undergo surgery.InterventionsBilateral breast reduction surgery for women in the surgical cohort.Main outcome measuresThe primary outcome measure was health-related quality of life measured preoperatively and at 3, 6 and 12 months postoperatively using the Short Form-36 (SF-36) questionnaire. Secondary outcome measures included post-surgical complications.Results209 patients in the surgical cohort completed questionnaires before and after surgery. 124 patients in the control hypertrophy cohort completed baseline and 12-month follow-up questionnaires. At baseline, both groups had significantly lower scores compared with population norms across all scales (p<0.001). In the surgical cohort significant improvements were seen across all eight SF-36 scales (p<0.001) following surgery. Within 3 months of surgery scores were equivalent to those of the normal population and this improvement was sustained at 12 months. SF-36 physical and mental component scores both significantly improved following surgery, with a mean change of 10.2 and 9.2 points, respectively (p<0.001). In contrast, SF-36 scores for breast hypertrophy controls remained at baseline across 12 months. The improvement in quality of life was independent of breast resection weight and body mass index.ConclusionBreast reduction significantly improved quality of life in women with breast hypertrophy. This increase was most pronounced within 3 months of surgery and sustained at 12-month follow-up. This improvement in quality of life is comparable to other widely accepted surgical procedures. Furthermore, women benefit from surgery regardless of factors including body mass index and resection weight.


2006 ◽  
Vol 93 (3) ◽  
pp. 291-294 ◽  
Author(s):  
O. C. Iwuagwu ◽  
L. G. Walker ◽  
P. W. Stanley ◽  
N. B. Hart ◽  
A. J. Platt ◽  
...  

2012 ◽  
Vol 69 (4) ◽  
pp. 361-363 ◽  
Author(s):  
Marco A. Gonzalez ◽  
Laurence T. Glickman ◽  
Bola Aladegbami ◽  
Roger L. Simpson

Author(s):  
Dafna Yaacobi ◽  
Asaf Olshinka ◽  
Tal Shachar ◽  
Alex Lvovsky ◽  
Tamir Shay ◽  
...  

Abstract Background Macromastia (breast hypertrophy) has significant influence on patients' quality of life (QoL), therefore surgical treatment has a clear medical benefit. Rapid improvements in musculoskeletal complaints are being reported long before when final aesthetic results are traditionally evaluated. Objectives The study aim is to use the RAND Health Status Survey, a modified validated short-form-36, to analyze patient QoL after breast reduction, and examine whether QoL changes as a function of time post operation. Methods In this cross-sectional study, included were 50 consecutive selected female patients who underwent breast reduction surgery during January 2016 - December 2019, by a single surgeon using the same technique. Changes in QoL were reported based on a modified SF-36 survey, with scores standardized according to the mean of the general population. Time intervals between the operations and surveys were recorded. Results The patients were divided into three categories according to time since their operation (˂3 months, 3-12 months and ˃12 months), and assessed pre- and post-operatively. Average amount of breast tissue removed was 479.97±159.38 grams per breast. Mean follow-up time was 15.02±14.3 months. All patients were satisfied with their new breasts' shapes and none reported to have suffered major complications postoperatively. For all three groups, patients' scores in the SF36 survey post- compared to pre-operation indicated improvement unrelated to time elapsed from operation. Conclusions Breast reduction improves symptoms and well-being, unrelated to amount of tissue removed nor to time elapsed post-surgery. This improvement is rapid and may lead to better coverage from medical insurance providers.


Sign in / Sign up

Export Citation Format

Share Document